Prevalence and Species Distribution of Candida Infection Among HIV Patients in Makurdi, Nigeria

Imagine your body as a bustling, high-security city. Inside this city, a special police force called the immune system patrols the streets, keeping unwanted invaders in check. Usually, this force is so effective that tiny, harmless squatters living in the city—like a fungus called Candida—never cause trouble. They just hang out quietly. But sometimes, a virus called HIV breaks into the city hall and shuts down the police station. Without the police, the city's defenses crumble, and those quiet squatters can turn into a chaotic mob, taking over neighborhoods and making the residents very sick. This is what doctors call an "opportunistic infection."

In many parts of the world, doctors have a powerful tool to fix the police station: a daily medication called Antiretroviral Therapy, or ART. When people take ART, the virus is pushed back, the police force starts working again, and the fungal mobs usually shrink. But here's the mystery: even with the medicine, the fungal squatters don't always leave. Scientists want to know exactly how often this happens, which specific types of fungi are causing the trouble, and if the medicine is working as well as we hope in different places. This is the story of a new investigation into that very question.

---

The Great Fungal Hunt in Makurdi

In the city of Makurdi, Nigeria, two researchers decided to play detective. They wanted to see how many people living with HIV were dealing with a Candida infection and what kind of Candida it was. They visited two hospitals—Benue State University Teaching Hospital and General Hospital North Bank—and invited 233 patients to join their study.

Think of these patients as two different teams. The first team, which was huge (218 people), was already taking the HIV medicine (ART). The second team was tiny (only 15 people) and hadn't started the medicine yet. The researchers took swabs—like using a long, sterile Q-tip—from two places: inside the mouth and, for women, from the vaginal area. They then grew whatever was on those swabs in a special jelly called Sabouraud Dextrose Agar, which acts like a fungal garden, letting the invisible invaders grow big enough to see.

What They Found

The results were a bit surprising. Almost half of everyone they tested—49.4% (that's 115 out of 233 people)—had a Candida infection.

When they looked at the two teams, they saw a trend, but not a "statistically significant" one (which means the difference wasn't big enough to say it was definitely caused by the medicine and not just luck).

• The Medicine Team: 48.2% of the people taking ART had the infection.
• The No-Medicine Team: 66.7% of the people not taking ART had the infection.

So, while the people without medicine seemed to have more trouble, the fact that nearly half the people on medicine still had the infection suggests that the medicine helps, but it doesn't magically make the fungus disappear for everyone.

The researchers also noticed some interesting patterns about who got sick:

• Gender: Women were much more likely to have the infection than men. Out of all the positive cases, 64.3% were female.
• Age: The most common age group to have the infection was people between 31 and 40 years old. This group made up 34.8% of the infected cases.
• Location: The infection was slightly more common at the General Hospital North Bank (54.7%) than at the University Teaching Hospital (44.0%), but again, this difference wasn't big enough to be a hard rule.

The Villains: Who Was in the Garden?

Once the fungi grew in their "garden," the researchers had to identify the villains. They found that the most common bad guy was Candida albicans. This is the classic, well-known type of fungus. It was the boss in both the mouth and the vaginal samples.

However, there were also some "non-albicans" species—different, stranger cousins of the fungus. These were found more often in the mouth samples than in the vaginal ones. The researchers couldn't name exactly which cousins they were (like C. glabrata or C. krusei) because their testing method stopped at a certain point, but they knew these other types were there.

The Takeaway

The main lesson from this study is that even though HIV patients in Makurdi are getting treatment, fungal infections are still a huge problem. The medicine helps lower the rates, but it doesn't stop the infection completely. The fact that so many women and people in their 30s and 40s are affected, and that different types of fungi are showing up, tells doctors that they need to keep a close eye on these patients.

The researchers suggest that simply giving HIV medicine isn't the whole story. Doctors might need to check for these fungal infections more often, help patients stick to their medicine schedules, and keep an eye out for fungi that might be getting tough to kill. It's a reminder that in the battle for a healthy city, you have to keep the police force strong and watch out for the squatters who refuse to leave.